(Q34292169)

English

Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Adaptive radiation therapy

0 references

David Titelbaum

object named as

David Titelbaum

4

0 references

Cancer and Leukemia Group B

11

object named as

Cancer and Leukemia Group B

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

10

object named as

Eric J Small

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2

object named as

Susan Halabi

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Anthony V D'Amico

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Clare Tempany

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

George K Philips

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Marian Loffredo

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Elizabeth McMahon

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Ben Sanford

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Nicholas J Vogelzang

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

26 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

9-15

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

6 July 2018

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

6 July 2018

Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

6 July 2018

Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

6 July 2018

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

6 July 2018

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

6 July 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

6 July 2018

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

6 July 2018

MR imaging of the prostate and bladder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

6 July 2018

Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

6 July 2018

Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

28 October 2018

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

28 October 2018

Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976647

28 October 2018

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy Findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nadir prostate-specific antigen best predicts the progression to androgen-independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18037582

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.IJROBP.2007.09.033

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34292169&oldid=2186441111"